Haemonetics Corp (STU:HAZ)
€ 65.5 (0%) Market Cap: 2.99 Bil Enterprise Value: 3.85 Bil PE Ratio: 37.13 PB Ratio: 4.26 GF Score: 84/100

Haemonetics Corp at Goldman Sachs Healthcare Conference Transcript

Jun 08, 2026 / 08:00PM GMT
Release Date Price: €65 (+5.69%)
Unidentified Participant

Good afternoon, everyone. Pleased to welcome you to (inaudible) -- our last session of day 1 of the conference.

Very pleased to welcome Chris Simon, President and CEO of Haemonetics. Thank you, again, for making the trip to Miami.

We were catching up before this. It's been a long time (multiple speakers) --

Christopher Simon
Haemonetics Corp - President, Chief Executive Officer, Director

Long time.

Unidentified Participant

-- since I saw you. You were here last year. But, obviously, we go back much farther than that in terms of the evolution of the company.

Questions & Answers

Unidentified Participant

Maybe just -- you've completed an LRP. You've just set out fiscal year guidance. Talk to us -- like, where are you in this transformation of Haemonetics?

Christopher Simon
Haemonetics Corp - President, Chief Executive Officer, Director

Thanks. Thanks for having us at the conference. Delighted to be

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot